HQL

Abrdn Life Sciences Investors

Finans

NOT REVIEWED — A definitive compliance result cannot be given for this company because one or more ratios could not be calculated.

$18.42

Price (1 Year)

$22.38 $15.87

Participation Finance Screening Ratios

Non-compliant debt / Total market capNo data
Non-compliant assets / Total market capNo data
Non-compliant revenue / Total incomeNo data

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.